Cureus - 29 Apr 2024
Semaglutide (Ozempic), a GLP-1 receptor agonist effective in weight management, and ziprasidone (Geodon), an antipsychotic with a lower risk of metabolic ...
The Journal of Clinical Psychiatry - 19 Nov 2024
What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia? ...
Nature.com - 21 Nov 2024
Networks extracted from nonlinear fMRI connectivity exhibit unique spatial variation and enhanced sensitivity to differences between individuals with schizophrenia and controls ...